SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andrew Brodbelt, David Greenberg, Tim Winters, Matt Williams, Sally Vernon, V. Peter Collins, Glioblastoma in England: 2007–2011, European Journal of Cancer, 2015,

    CrossRef

  2. 2
    Rafaela Muniz de Queiroz, Christina Maeda Takiya, Lívia Paes Tavares Pacheco Guimarães, Gleice da Graça Rocha, Daniela Sales Alviano, Arie Fitzgerald Blank, Celuta Sales Alviano, Cerli Rocha Gattass, Apoptosis-Inducing Effects ofMelissa officinalisL. Essential Oil in Glioblastoma Multiforme Cells, Cancer Investigation, 2014, 32, 6, 226

    CrossRef

  3. 3
    Yu Zhang, Melanie Köllmer, Jason S. Buhrman, Mary Y. Tang, Richard A. Gemeinhart, Arginine-rich, cell penetrating peptide–anti-microRNA complexes decrease glioblastoma migration potential, Peptides, 2014, 58, 83

    CrossRef

  4. 4
    Mario E. Lacouture, Mary Elizabeth Davis, Grace Elzinga, Nicholas Butowski, David Tran, John L. Villano, Lucianna DiMeglio, Angela M. Davies, Eric T. Wong, Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma, Seminars in Oncology, 2014, 41, S1

    CrossRef

  5. 5
    L. Wang, B. Zhang, X. Xu, S. Zhang, X. Yan, F. Kong, X. Feng, J. Wang, Clinical significance of FOXP3 expression in human gliomas, Clinical and Translational Oncology, 2014, 16, 1, 36

    CrossRef

  6. 6
    Adelheid Woehrer, Luc Bauchet, Jill S. Barnholtz-Sloan, Glioblastoma survival, Current Opinion in Neurology, 2014, 1

    CrossRef

  7. 7
    N. D. Arvold, Y. Wang, C. Zigler, D. Schrag, F. Dominici, Hospitalization burden and survival among older glioblastoma patients, Neuro-Oncology, 2014, 16, 11, 1530

    CrossRef

  8. 8
    Lijun Sun, Xiwen Chen, Xingnan Jin, Qiang Huang, Weilan Wang, Dashi Zhi, Defu Chen, Identification and Characterization of Human MIBP1 Gene in Glioma Cell Differentiation, Journal of Molecular Neuroscience, 2014, 52, 2, 294

    CrossRef

  9. 9
    Jeffrey J. Olson, Timothy Charles Ryken, Steven N. Kalkanis, Introduction, rationale, and methodology, Journal of Neuro-Oncology, 2014, 118, 3, 429

    CrossRef

  10. 10
    Mitchell S. Wachtel, Shengping Yang, Odds of death after glioblastoma diagnosis in the United States by chemotherapeutic era, Cancer Medicine, 2014, 3, 3
  11. 11
    N. Badaoui, D. Meyronet, S. Cartalat-Carel, J. Guyotat, E. Jouanneau, A. d’Hombres, M.P. Sunyach, A. Jouvet, G. Louis-Tisserand, A. Archinet, D. Frappaz, L. Bauchet, J. Honnorat, F. Ducray, Patterns of care and survival of glioblastoma patients: A comparative study between 2004 and 2008 in Lyon, France, Revue Neurologique, 2014, 170, 3, 222

    CrossRef

  12. 12
    Rafael Fuentes-Raspall, Montserrat Puig-Vives, Silvia Guerra-Prio, Ferran Perez-Bueno, Rafael Marcos-Gragera, Population-based survival analyses of central nervous system tumors from 1994 to 2008. An up-dated study in the temozolomide-era, Cancer Epidemiology, 2014, 38, 3, 244

    CrossRef

  13. 13
    Q. T. Ostrom, L. Bauchet, F. G. Davis, I. Deltour, J. L. Fisher, C. E. Langer, M. Pekmezci, J. A. Schwartzbaum, M. C. Turner, K. M. Walsh, M. R. Wrensch, J. S. Barnholtz-Sloan, The epidemiology of glioma in adults: a "state of the science" review, Neuro-Oncology, 2014, 16, 7, 896

    CrossRef

  14. 14
    Elizabeth M. Haley, Yonghyun Kim, The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture, Cancer Letters, 2014, 346, 1, 1

    CrossRef

  15. 15
    Timothy Charles Ryken, Steven N. Kalkanis, John M. Buatti, Jeffrey J. Olson, The role of cytoreductive surgery in the management of progressive glioblastoma, Journal of Neuro-Oncology, 2014, 118, 3, 479

    CrossRef

  16. 16
    Jeffrey J. Olson, Lakshmi Nayak, D. Ryan Ormond, Patrick Y. Wen, Steven N. Kalkanis, The role of cytotoxic chemotherapy in the management of progressive glioblastoma, Journal of Neuro-Oncology, 2014, 118, 3, 501

    CrossRef

  17. 17
    Timothy Charles Ryken, Nafi Aygun, Johnathan Morris, Marin Schweizer, Rajeshwari Nair, Cassandra Spracklen, Steven N. Kalkanis, Jeffrey J. Olson, The role of imaging in the management of progressive glioblastoma, Journal of Neuro-Oncology, 2014, 118, 3, 435

    CrossRef

  18. 18
    Daniel J. Brat, Timothy Charles Ryken, Steven N. Kalkanis, Jeffrey J. Olson, The role of neuropathology in the management of progressive glioblastoma, Journal of Neuro-Oncology, 2014, 118, 3, 461

    CrossRef

  19. 19
    Samuel Ryu, John M. Buatti, Ann Morris, Steven N. Kalkanis, Timothy Charles Ryken, Jeffrey J. Olson, The role of radiotherapy in the management of progressive glioblastoma, Journal of Neuro-Oncology, 2014, 118, 3, 489

    CrossRef

  20. 20
    Jeffrey J. Olson, Lakshmi Nayak, D. Ryan Ormond, Patrick Y. Wen, Steven N. Kalkanis, Timothy Charles Ryken, The role of targeted therapies in the management of progressive glioblastoma, Journal of Neuro-Oncology, 2014, 118, 3, 557

    CrossRef

  21. 21
    Ke Sai, Wen-Yu Li, Yin-Sheng Chen, Jian Wang, Su Guan, Qun-Ying Yang, Cheng-Cheng Guo, Yong-Gao Mou, Wei-Ping Li, Zhong-Ping Chen, Triptolide Synergistically Enhances Temozolomide-Induced Apoptosis and Potentiates Inhibition of NF-κB Signaling in Glioma Initiating Cells, The American Journal of Chinese Medicine, 2014, 42, 02, 485

    CrossRef

  22. 22
    Wen-Zhong Du, Yan Feng, Xiao-Feng Wang, Xing-Yin Piao, Yu-Qiong Cui, Ling-Chao Chen, Xu-Hui Lei, Xu Sun, Xing Liu, Han-Bing Wang, Xian-Feng Li, Dong-Bo Yang, Ying Sun, Zhe-Feng Zhao, Tao Jiang, Yong-Li Li, Chuan-Lu Jiang, Curcumin Suppresses Malignant Glioma Cells Growth and Induces Apoptosis by Inhibition of SHH/GLI1 Signaling Pathway in Vitro and Vivo, CNS Neuroscience & Therapeutics, 2013, 19, 12
  23. 23
    Derek R. Johnson, Heather E. Leeper, Joon H. Uhm, Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: A population-based analysis, Cancer, 2013, 119, 19
  24. 24
    Izaskun Valduvieco, Eugènia Verger, Jordi Bruna, Lluís Caral, Teresa Pujol, Teresa Ribalta, Teresa Boget, Laura Oleaga, Estela Pineda, Francesc Graus, Impact of radiotherapy delay on survival in glioblastoma, Clinical and Translational Oncology, 2013, 15, 4, 278

    CrossRef

  25. 25
    Sara Fritzell, Emma Sandén, Sofia Eberstål, Edward Visse, Anna Darabi, Peter Siesjö, Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion, Cancer Immunology, Immunotherapy, 2013, 62, 9, 1463

    CrossRef

  26. 26
    F. Graus, J. Bruna, J. Pardo, D. Escudero, D. Vilas, I. Barcelo, M. Brell, C. Pascual, J. A. Crespo, E. Erro, J. C. Garcia-Romero, J. Estela, J. Martino, A. Garcia-Castano, E. Mata, M. Lema, M. Gelabert, R. Fuentes, P. Perez, A. Manzano, J. Aguas, A. Belenguer, A. Simon, I. Henriquez, M. Murcia, R. Vivanco, I. Rojas-Marcos, D. Munoz-Carmona, I. Navas, P. de Andres, G. Mas, M. Gil, E. Verger, Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain, Neuro-Oncology, 2013, 15, 6, 797

    CrossRef

  27. 27
    Gary V. Walker, Mark R. Gilbert, Sujit S. Prabhu, Paul D. Brown, Mary Frances McAleer, Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice, Journal of Neuro-Oncology, 2013, 112, 1, 83

    CrossRef

  28. 28
    P. J. Slotty, B. Siantidis, T. Beez, H. J. Steiger, M. Sabel, The impact of improved treatment strategies on overall survival in glioblastoma patients, Acta Neurochirurgica, 2013, 155, 6, 959

    CrossRef

  29. 29
    R. Dubrow, A. S. Darefsky, D. I. Jacobs, L. S. Park, M. G. Rose, M. S. H. Laurans, J. T. King, Time trends in glioblastoma multiforme survival: the role of temozolomide, Neuro-Oncology, 2013, 15, 12, 1750

    CrossRef

  30. 30
    T T Huang, J Hlavaty, D Ostertag, F L Espinoza, B Martin, H Petznek, M Rodriguez-Aguirre, C E Ibañez, N Kasahara, W Gunzburg, H E Gruber, D Pertschuk, D J Jolly, J M Robbins, Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model, Cancer Gene Therapy, 2013, 20, 10, 544

    CrossRef

  31. 31
    Kyu-Won Jung, Heon Yoo, Hyun-Joo Kong, Young-Joo Won, Sohee Park, Seung Hoon Lee, Population-based survival data for brain tumors in Korea, Journal of Neuro-Oncology, 2012, 109, 2, 301

    CrossRef

  32. 32
    Yasuaki Harasaki, Allen Waziri, Potential Usefulness of Radiosensitizers in Glioblastoma, Neurosurgery Clinics of North America, 2012, 23, 3, 429

    CrossRef

  33. 33
    Ulf Dietrich Kahlert, Donata Maciaczyk, Fangping Dai, Rainer Claus, Elke Firat, Soroush Doostkam, Tomasz Bogiel, Maria Stella Carro, Mate Döbrössy, Christel Herold-Mende, Gabriele Niedermann, Marco Prinz, Guido Nikkhah, Jaroslaw Maciaczyk, Resistance to Hypoxia-Induced, BNIP3-Mediated Cell Death Contributes to an Increase in a CD133-Positive Cell Population in Human Glioblastomas In Vitro, Journal of Neuropathology & Experimental Neurology, 2012, 71, 12, 1086

    CrossRef

  34. 34
    Daniel T. Nagasawa, Frances Chow, Andrew Yew, Won Kim, Nicole Cremer, Isaac Yang, Temozolomide and Other Potential Agents for the Treatment of Glioblastoma Multiforme, Neurosurgery Clinics of North America, 2012, 23, 2, 307

    CrossRef

  35. 35
    Matthew Lyons, Isaac Phang, Sam Eljamel, The effects of PDT in primary malignant brain tumours could be improved by intraoperative radiotherapy, Photodiagnosis and Photodynamic Therapy, 2012, 9, 1, 40

    CrossRef